Tara Harris

7.4k total citations · 1 hit paper
24 papers, 485 citations indexed

About

Tara Harris is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Tara Harris has authored 24 papers receiving a total of 485 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 9 papers in Infectious Diseases and 7 papers in Health. Recurrent topics in Tara Harris's work include Vaccine Coverage and Hesitancy (7 papers), Respiratory viral infections research (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Tara Harris is often cited by papers focused on Vaccine Coverage and Hesitancy (7 papers), Respiratory viral infections research (6 papers) and SARS-CoV-2 and COVID-19 Research (4 papers). Tara Harris collaborates with scholars based in Canada, United States and South Africa. Tara Harris's co-authors include Shelley L. Deeks, Sarah E. Wilson, Jyotsna Nair, Sarah A. Buchan, Caitlin Johnson, Sharifa Nasreen, Andrew Calzavara, Gillian Lim, Jeffrey C. Kwong and Shalini Desai and has published in prestigious journals such as PLoS ONE, Scientific Reports and Obstetrics and Gynecology.

In The Last Decade

Tara Harris

23 papers receiving 471 citations

Hit Papers

Epidemiology of Myocarditis and Pericarditis Following mR... 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tara Harris Canada 12 200 198 126 83 81 24 485
Hazel J Clothier Australia 14 250 1.3× 237 1.2× 156 1.2× 36 0.4× 92 1.1× 57 586
Patricia Vermeer United States 6 141 0.7× 220 1.1× 76 0.6× 35 0.4× 133 1.6× 7 430
Parveen Fathima Australia 15 438 2.2× 160 0.8× 116 0.9× 24 0.3× 75 0.9× 48 592
Robin Marlow United Kingdom 12 140 0.7× 216 1.1× 75 0.6× 46 0.6× 25 0.3× 38 417
Fadima Cheick Haidara Mali 9 136 0.7× 133 0.7× 39 0.3× 42 0.5× 27 0.3× 24 262
Fong Seng Lim Singapore 11 201 1.0× 152 0.8× 42 0.3× 84 1.0× 28 0.3× 19 394
Rachel Herlihy United States 14 252 1.3× 267 1.3× 111 0.9× 124 1.5× 33 0.4× 29 597
Oidda Museru United States 9 134 0.7× 89 0.4× 82 0.7× 29 0.3× 82 1.0× 16 284
Satoshi Kamidani United States 8 42 0.2× 186 0.9× 101 0.8× 31 0.4× 36 0.4× 20 268
George Kassianos United Kingdom 16 532 2.7× 117 0.6× 188 1.5× 59 0.7× 19 0.2× 42 747

Countries citing papers authored by Tara Harris

Since Specialization
Citations

This map shows the geographic impact of Tara Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tara Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tara Harris more than expected).

Fields of papers citing papers by Tara Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tara Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tara Harris. The network helps show where Tara Harris may publish in the future.

Co-authorship network of co-authors of Tara Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Tara Harris. A scholar is included among the top collaborators of Tara Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tara Harris. Tara Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grewal, Ramandip, et al.. (2024). Invasive Pneumococcal Disease Epidemiology and Serotype Replacement After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Ontario, Canada, 2007–2022. Open Forum Infectious Diseases. 11(6). ofae275–ofae275. 2 indexed citations
2.
Buchan, Sarah A., Caitlin Johnson, Jeffrey C. Kwong, et al.. (2023). Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada. JAMA Pediatrics. 177(4). 410–410. 7 indexed citations
3.
4.
Buchan, Sarah A., Caitlin Johnson, Jeffrey C. Kwong, et al.. (2022). Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada. JAMA Network Open. 5(6). e2218505–e2218505. 102 indexed citations breakdown →
5.
Wilson, Sarah E., Laura C. Rosella, Jun Wang, et al.. (2019). Equity and impact: Ontario’s infant rotavirus immunization program five years following implementation. A population-based cohort study. Vaccine. 37(17). 2408–2414. 7 indexed citations
6.
Stapleton, Patrick J., Alireza Eshaghi, Sarah E. Wilson, et al.. (2019). Evaluating the use of whole genome sequencing for the investigation of a large mumps outbreak in Ontario, Canada. Scientific Reports. 9(1). 12615–12615. 13 indexed citations
7.
Lim, Gillian, et al.. (2019). The shifting epidemiology and serotype distribution of invasive pneumococcal disease in Ontario, Canada, 2007-2017. PLoS ONE. 14(12). e0226353–e0226353. 48 indexed citations
8.
Wormsbecker, Anne, et al.. (2019). Demonstration of background rates of three conditions of interest for vaccine safety surveillance. PLoS ONE. 14(1). e0210833–e0210833. 4 indexed citations
9.
Harris, Tara, et al.. (2017). Assessment of sex-specific differences in adverse events following immunization reporting in Ontario, 2012–15. Vaccine. 35(19). 2600–2604. 52 indexed citations
10.
Wilson, Sarah E., Laura C. Rosella, Jun Wang, et al.. (2016). Population-Level Impact of Ontario’s Infant Rotavirus Immunization Program: Evidence of Direct and Indirect Effects. PLoS ONE. 11(5). e0154340–e0154340. 26 indexed citations
11.
Pathirana, Jayani, Flor M. Muñoz, Victoria Abbing‐Karahagopian, et al.. (2016). Neonatal death: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 34(49). 6027–6037. 69 indexed citations
12.
Harris, Tara, et al.. (2016). Assessing vaccine safety within Ontario’s Universal Influenza Immunization Program, 2012-2013 to 2014-2015. Canada Communicable Disease Report. 42(9). 181–186. 2 indexed citations
13.
Harris, Tara, et al.. (2015). A spot of bother: Why varicella vaccine programs matter. Canada Communicable Disease Report. 41(10). 241–249. 2 indexed citations
14.
Harris, Tara, et al.. (2014). Vaccine safety implications of Ontario, Canada's switch from DTaP–IPV to Tdap–IPV for the pre-school booster. Vaccine. 32(48). 6360–6363. 7 indexed citations
15.
Harris, Tara, et al.. (2014). Adverse events following immunization in Ontario's female school-based HPV program. Vaccine. 32(9). 1061–1066. 23 indexed citations
16.
Harris, Tara, et al.. (2013). Group Diabetes Self-Management Education in a Primary Care Setting. Journal of Nursing Care Quality. 29(2). 188–193. 5 indexed citations
17.
Wilson, Sarah E., et al.. (2012). Coverage from Ontario, Canada's school-based HPV vaccine program: The first three years. Vaccine. 31(5). 757–762. 27 indexed citations
18.
Harris, Tara, et al.. (2011). Addendum to the 2010-2011 Seasonal Trivalent Inactivated Influenza Vaccine. Canada Communicable Disease Report. 37(ACS-4). 1–39. 3 indexed citations
19.
Ismail, Shainoor J., et al.. (2010). Canada's National Advisory Committee on Immunization (NACI): Evidence-based decision-making on vaccines and immunization. Vaccine. 28. A58–A63. 38 indexed citations
20.
Harris, Tara, et al.. (2006). HIV Testing among Canadian Tuberculosis Cases from 1997 to 1998. Canadian Journal of Infectious Diseases and Medical Microbiology. 17(3). 165–168. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026